Berlex, Inc., a U.S. affiliate of Bayer Schering Pharma, Germany, announced today that the U.S. Food and Drug Administration has approved a new indication for YAZ® to treat moderate acne vulgaris in women who desire an oral contraceptive for birth control.
From: biz.yahoo.com
R) to Treat Acne
Posted by Ruslan Abuzant at 1:00 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment